Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Inhibitor Therapeutics, Inc. | d938337d10q.htm |
| EX-4.1 - WARRANT - Inhibitor Therapeutics, Inc. | d938337dex41.htm |
| EX-31.2 - CERIFICATION - Inhibitor Therapeutics, Inc. | d938337dex312.htm |
| EX-10.5 - SECURITIES PURCHASE AGREEMENT - Inhibitor Therapeutics, Inc. | d938337dex105.htm |
| EX-10.6 - MASTER CLINICAL SERVICES AGREEMENT - Inhibitor Therapeutics, Inc. | d938337dex106.htm |
| EX-10.2 - FIRST AMENDMENT TO EXECUTIVE CHAIRMAN AGREEMENT - Inhibitor Therapeutics, Inc. | d938337dex102.htm |
| EX-10.1 - AMENDED AND RESTATED EQUITY HOLDERS AGREEMENT - Inhibitor Therapeutics, Inc. | d938337dex101.htm |
| EX-31.1 - CERIFICATION - Inhibitor Therapeutics, Inc. | d938337dex311.htm |
| EX-32.1 - CERTIFICATION - Inhibitor Therapeutics, Inc. | d938337dex321.htm |
| EX-10.3 - FIRST AMENDMENT TO EMPLOYMENT AGREEMENT - Inhibitor Therapeutics, Inc. | d938337dex103.htm |
| EX-10.4 - SECOND AMENDED AND RESTATED SUPPLY AND LICENSE AGREEMENT - Inhibitor Therapeutics, Inc. | d938337dex104.htm |
Exhibit 32.2
HEDGEPATH PHARMACEUTICALS, INC.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of HedgePath Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Garrison J. Hasara, Treasurer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| /s/ Garrison J. Hasara |
| Garrison J. Hasara |
| Chief Financial Officer and Treasurer |
| August 14, 2015 |